Previous close | 518.36 |
Open | 519.39 |
Bid | N/A x N/A |
Ask | N/A x N/A |
Day's range | 524.52 - 531.72 |
52-week range | 446.52 - 557.99 |
Volume | |
Avg. volume | 59,318 |
Market cap | N/A |
Beta (5Y monthly) | 0.59 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | 16 Jul 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Walgreens CEO Tim Wentworth is reversing his predecessors' course to focus more on retail pharmacy needs in communities compared to a more vertically integrated healthcare strategy.
Shares of UnitedHealth Group (UNH) are moving after the company's subsidiary, OptumRx Inc., a prescription drug benefit provider, agreed to a $20 million settlement after the US government claimed the provider improperly filled certain opioid prescriptions. Yahoo Finance Anchors Madison Mills and Seana Smith break down the headwinds for UnitedHealth Group. For more expert insight and the latest market action, click here to watch this full episode of Catalysts. This post was written by Nicholas Jacobino
Key Insights Given the large stake in the stock by institutions, UnitedHealth Group's stock price might be vulnerable...